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Surface nodulechanisms that guide the proper development of epicardial cell lineages is critical
for understanding the etiology of both congenital and adult forms of human cardiovascular disease. In this
study, we describe the function of BAF180, a polybromo protein in ATP-dependent SWI/SNF chromatin
remodeling complexes, in coronary development. Ablation of BAF180 leads to impaired epithelial-to-
mesenchymal-transition (EMT) and arrested maturation of epicardium around E11.5. Three-dimensional
collagen gel assays revealed that the BAF180 mutant epicardial cells indeed possess signiﬁcantly com-
promised migrating and EMT potentials. Consequently, the mutant hearts form abnormal surface nodules
and fail to develop the ﬁne and continuous plexus of coronary vessels that cover the entire ventricle around
E14. PECAM and α-SMA staining assays indicate that these nodules are defective structures resulting from
the failure of endothelial and smooth muscle cells within them to form coronary vessels. PECAM staining also
reveal that there are very few coronary vessels inside the myocardium of mutant hearts. Consistent with this,
quantitative RT-PCR analysis indicate that the expression of genes involved in FGF, TGF, and VEGF pathways
essential for coronary development are down-regulated in mutant hearts. Together, these data reveal for the
ﬁrst time that BAF180 is critical for coronary vessel formation.
© 2008 Elsevier Inc. All rights reserved.IntroductionCoronary vessel development consists of a series of dynamic events
(Mu et al., 2005; Reese et al., 2002; Tomanek 2005). Although the origin
of certain cell types is not entirely clear (Jiang et al., 2000; Mikawa and
Gourdie,1996;Moretti et al., 2006; Perez-Pomares et al., 2002; Poelmann
et al., 1993), it is well established that the precursors of the coronary
vessel and epicardium arise mostly from the proepicardium (PE). Cells
from thePEmigrate to and then envelope the heart to form the primitive
epicardiumaroundE9.5 inmice. Shortlyafterwards, someepicardial cells
undergo an EMT to becomemigratory mesenchymal cells (E11.5–E12.5),
andgive rise tovascular smoothmuscle, perivascularﬁbroblasts, andalso
perhapsendothelial cells of thecoronaryvessels. Primaryvascularplexus
is formed by vasculogenesis (de novo generation of blood vessels), and
then the major coronary vessels, smaller-caliber arteries, veins, and
capillaries are formed by angiogenesis. Finally, after joining the geneal
circulatory system by E13, the discontinuous and randomly oriented
coronary vessels connect, expand, and orient to form the functional
coronary network.
Tissue differentiation and organ formation such as coronary vessel
development require signal-dependent and tissue- and stage-speciﬁcl rights reserved.gene expression. The speciﬁc gene expression program is ensured by
chromatin modifying enzymes to make gene-speciﬁc DNA accessible
to the transcription machinery in response to developmental signals.
Among them, ATP-dependent chromatin remodeling complexes and
histonemodifying complexes are twowell-deﬁned classes (Narlikar et
al., 2002). ATP-dependent chromatin remodeling complexes are spe-
cialized multi-protein machines that utilize ATP to modify nucleo-
somes or higher order chromatin structures to regulate access to the
DNA. The chromatin remodeling factors are themselves often
classiﬁed as transcription cofactors: chromatin remodeling is inti-
mately linked to transcription, and the remodeling factors often
physically interact with transcription factors or cofactors and can
potentiate transcriptional activity of certain activators (Levine and
Tjian, 2003).
The delicate and dynamic nature of tissue differentiation and organ
development dictates that the chromatin remodeling activity must be
highly speciﬁc for the tissue-, stage-, or gene cluster. This is indicated
by the large number of different chromatin remodeling complexes and
the tissue- or developmental stage-speciﬁc composition of the sub-
units within a particular complex. There are ﬁve families of chromatin
remodeling complexes identiﬁed so far: SWI/SNF, ISWI, NURD/Mi-2/
CHD, INO80, and SWR1, and numerous complexes have been dis-
covered within each family (Saha et al., 2006). In addition, the com-
position of a particular complex can be also tissue- or stage-speciﬁc.
For example, heart- and neuron-speciﬁc subunits have been identiﬁed
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al., 2004; Wu et al., 2007). And indeed, the heart-speciﬁc BAF60c in
SWI/SNF complexes is required for early heart formation (Lickert et al.,
2004), and the neuron-speciﬁc BAF53b is essential for neuron den-
dritic pattern formation (Wu et al., 2007). Furthermore, neuron-
speciﬁc subunit composition switch is required for the transition from
neural stem/progenitors to postmitotic neurons (Lessard et al., 2007).
Despite the important biochemical functions and the identiﬁed roles at
various stages of development, the role for chromatin remodeling and
the speciﬁc chromatin remodeling factors essential for coronary
development have not been explored.
SWI/SNF complexes has been further characterized to include two
major subclasses: BAF and PBAF (Mohrmann and Verrijzer, 2005;
Moshkin et al., 2007; Wang, 2003). These complexes appear to be
evolutionarily conserved from yeast, to ﬂy, and to humans. Compo-
nents of BAF complexes can associate with Rb or HDACs for trans-
criptional repression (Zhang et al., 2000), or associate with CARM1 or
other factors for transcriptional activation (Xu et al., 2004). The two
complexes share eight common subunits but are distinguished by four
polypeptide components: BAF180 and BAF200 (unique to PBAF), and
BAF250a and BAF250b (both unique to BAF) (Wang, 2003; Yan et al.,
2005). Interestingly, a recent study identiﬁed another signature
subunit SAYP, a Trithorax group protein, in Drosophila PBAF complex
(Chalkley et al., 2008). These unique subunits may represent key
regulatory components that functionally distinguish PBAF from BAF,
as suggested by numerous studies (Chalkley et al., 2008; Lemon et al.,
2001; Moshkin et al., 2007; Yan et al., 2005).
In this study, we identiﬁed that BAF180, a polybromo protein
uniquely present in PBAF complex (Moshkin et al., 2007; Xue et al.,
2000), is critical for coronary development. We observed a sig-
niﬁcant reduction of epicardial cells in BAF180 mutant hearts that
underwent EMT and migrated into the subepicardial space at E11.5.
Three-dimensional collagen gel assays indicated that epicardial cells
lacking BAF180 are severely compromised in migration and EMT.
Consequently, the mutant hearts failed to develop the ﬁne and con-
tinuous plexus that covered the entire ventricle at later stages.
Numerous nodules were formed within the epicardium as a result
of a failure of epithelial and smooth muscle cells within these
structures to branch out to form vessels, and the coronary vessels
penetrated only slightly into the myocardium. Finally, we observed
that BAF180 regulates the expression of genes involved in FGF,
TGF, and VEGF signaling pathways, which are essential for coronary
development.Material and methods
Generation and identiﬁcation of BAF180 mutant embryos
A promoterless gene targeting strategy was applied to generate BAF180 mutant
mice as described (Wang et al., 2004). β-Geo, a fusion protein of β-galactosidase and
neomycin phosphotransferase, is inserted and spliced in frame to exon 11 of BAF180 in
the BAF180 mutants after homologous targeting, so β-galactosidase activity can
represent the expression of endogenous BAF180. A three-primer PCR analysis was
designed to distinguish the BAF180 wild-type (WT) from its mutants (Wang et al.,
2004). All the mice in this study were bred into CD1 genetic background for at least ﬁve
generations.
X-gal staining
Whole-mount X-gal staining was performed as described previously (Wang et al.,
2004). E9.5 embryos and E11.5 to E14.5 dissected hearts were ﬁxed in ﬁxation buffer
(0.2% glutaraldehyde, 0.1 M sodium phosphate, pH 7.3, 5 mM EGTA, 2 mMMgCl2) for 15
to 30min, thenwashed with 0.1 M phosphate, 2 mMMgCl2 wash buffer for three to ﬁve
times. Samples were then stained with staining buffer (1 mg/ml ﬁltered, freshly added
X-gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 0.1 M phosphate,
2 mM MgCl2) at room temperature overnight (O/N) or 37 °C for several hours. X-gal
stock solution was prepared at 50 mg/ml in dimethylformamide. After X-gal staining,
some samples were postﬁxed with 4% paraformaldehyde at 4 °C O/N, then dehydrated
and parafﬁn embedded. Sections of 6–8 μm were prepared on SuperFrost slides and
counter-stained with eosin.Hematoxylin and eosin (H&E) staining
Embryos at indicated stages were collected in ice-cold PBS, ﬁxed in 4% para-
formaldehyde at 4 °C O/N, washed in PBS, and dehydrated through an ethanol series
before parafﬁn embedding. Sections of 6 μm were prepared on SuperFrost slides and
stained with H&E as described (Wang et al., 2004).
PECAM staining
The whole-mount PECAM staining was performed as previously described
(Lavine et al., 2006). A 1:150 dilution of 1 μg/ml rat antibodies against mouse PECAM
(Pharmingen) in PBS, 1.5% skim milk, and 0.1% triton-100 and a 1:1000 dilution of
HRP-conjugated afﬁnity puriﬁed F(ab)2 fragment goat anti-rat IgG antibodies
(Jackson ImmunoResearch) were used for this assay. Color reaction was revealed
by peroxidase substrate DAB kit (DAKO). After PECAM staining, hearts or embryos
were photographed and analyzed. Some samples were parafﬁn embedded and
sectioned (6 μm). Sectioned samples were dewaxed, rehydrated, counterstained with
nuclear fast red (Vector Laboratories), and mounted. PECAM ﬂuorescent immuno-
histochemistry was performed with frozen sections as described (Lavine et al.,
2006). Coronary vessel density at the ventricular surface was quantitatively mea-
sured by counting the cycles among PECAM-positive vessels as described (Huang
et al., 2006).
PECAM and α-SMA double-ﬂuorescent-immunostaining
Freshly dissected embryonic hearts were embedded in OCT and snap frozen.
Cryosections were generated at 7 μm on a Leica Cryostat. The slides were heated at
50 °C for 1 h, washed with PBS, and then permeabilized with PBS/Triton X (0.25%).
After PBS wash and goat serum block, mouse antibodies against α-SMA (DAKO) and
rat antibodies against PECAM (Pharmingen) were incubated with the tissue. Alexa
594-conjugated goat anti-mouse (α-SMA) and Alexa 488-conjugated goat anti-rat
(PECAM) were used for the double-ﬂuorescent-immunostaining. DAPI was used to
stain nucleus.
Quantitative RT-PCR
Fresh embryonic hearts at indicated stages were dissected and RNAswere extracted
with the Tri-reagent (Sigma), and then puriﬁed by the Qiagen RNeasy miniprep system.
Typically, RNAs from 4 wild-type or mutant E11.5 hearts were used for one set. cDNAs
were prepared using Superscript III reverse transcriptase (Invitrogen) or Iscript™ cDNA
synthesis kit (Biorad) with standard procedures, and at least two independent cDNA
preparations were applied for the RT-PCR analysis. GAPDH was used as an internal
control for quantiﬁcation. PCR primers were designed to amplify 120–200-bp fragments
from the coding region of candidate genes. Primer sequences are available upon request.
RT-PCR was carried out with iQ™ SYBR green supermix (Biorad) in an Eppendorf
MastercyclerR ep realplex PCR machine. Fold-change in expression was determined by
the 2−ΔCT method described in the Eppendorf User Bulletin. P values for two variable
comparisons were calculated with Student's t test.
EMT evaluation: collagen gel assay
Hearts from embryonic day 12.5 were dissected and ventricular chambers were
placed epicardial side down on three-dimensional gels containing 1% collagen type I
(Vitrogen 100; Collagen Aesthetics, Palo Alto, CA), as described (Merki et al., 2005). After
48 h, the explanted hearts were removed and incubated for 72 h in DMEM medium
containing 10% FCS and supplemented with penicillin/Streptomycin and glutamine.
Transformation tomesenchymal cells was deﬁned as the invasion of cells into the three-
dimensional gels. The number of mesenchymal cells per monolayer was counted
manually using an inverted microscope equipped with phase contrast optics. Statistical
analysis: mesenchymal cells per monolayer were counted manually. Averages were
calculated and compared using Student's t test for two variable comparisons at a level
of signiﬁcance of p≤0.05.
Results
BAF180 is abundantly expressed in PE and epicardium
To better understand the cardiac tissue-speciﬁc function of
BAF180, we examined the expression pattern of BAF180 in heart
tissues during embryogenesis. β-Geo, a fusion protein of β-galacto-
sidase and neomycin phosphotransferase, is spliced in frame to a 5'
exon of BAF180 in the BAF180 mutants (Wang et al., 2004), so
β-galactosidase activity is a very sensitive way to show the expression
of endogenous BAF180. Indeed, X-gal staining revealed broad BAF180
expression in the heart tissues with abundant expression in PE and
epicardium (Fig. 1).
Fig. 1. BAF180 is highly expressed in PE and Epicardium. β-Geo was spliced in frame to a
5' exon of BAF180, so β-galactosidase activity reﬂects the expression of endogenous
BAF180. (A) Whole-mount X-gal staining of E9.5 BAF180+/+ and −/− embryos. Whole-
mount X-gal stained E9.5 (B) and E12.5 (C) embryonic hearts were sectioned and then
counter-stained with eosin.
Fig. 2. BAF180 ablation does not affect formation of the PE and migration of the PE cells
to cover the heart tube. (A) The PE forms normally in E9.5 BAF180 mutant embryos. (B)
The KO embryos also form a near complete epicardial layer covering the heart tube at
E10.5.
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PE cells to cover the heart tube
The high expression level of BAF180 in PE and epicardium suggest
that BAF180may be involved in the normal function of epicardial cells.
We therefore examined whether global deletion of BAF180 would
affect the formation of the PE and subsequent migration of cells from
the PE to cover the heart. A half dozen of E9.5 BAF180KO embryoswere
analyzed and it appeared that like the WT embryos (Fig. 2A, right
panel), the mutant embryos develop a normal PE (Fig. 2A, left panel).
Furthermore, in the mutant embryos, the PE cells form normal cysts
and migrate freely to the heart tube (Fig. 2A). At E10.5, the PE-derived
epicardial cells have coveredmost of the heart tube in both theWTand
the mutant embryonic hearts (Fig. 2B). Thus, neither the formation of
the PE nor the migration of the PE cells to form epicardium is affected
by BAF180 ablation.BAF180 ablation impairs the normal EMT of the epicardial cells for
coronary development
We next examined whether BAF180 regulates the EMT of the
epicardial cells. During embryonic development, shortly after the
migration of the PE cells to form the epicardium, a subepicardial space
ﬁlled with extracellular matrix appears between the epicardium and
myocardium. After covering the surface of the heart, a subpopulation of
the epicardial cells undergoes EMT and invades the subepicardial space
to subsequently give rise to coronary vessels (Reese et al., 2002;
Tomanek, 2005). The subepicardial matrix is a transient structure
observed in themouse hearts betweenE10.5 andE11.5 that separates the
primitive epicardium from themyocardium. It is ﬁlledwith proteins and
growth factors critical for theEMTof epicardial cells (Muet al., 2005), and
recesses after epicardial remodeling, which renders the myocardium in
direct contact to the epicardium.
H&E staining of E11.5 embryos revealed an underdeveloped
subepicardial space in the mutant hearts with a reduced number of
mesenchymal cells compared to their WT littermates (Fig. 3A, com-
pare left panel to right panel), suggesting impaired EMT in the BAF180
mutant hearts. In addition, this primitive, underdeveloped epicardium
is sustained in older mutant hearts, and fails to remodel and compact
(compare Figs. 3B and 3C).
To further establishwhether BAF180 is involved in the proper EMTof
epicardial cells, we analyzed the potential of BAF180 mutant epicardial
explants to convert into mesenchymal cells and migrate using the
collagen gel assays. Consistent differences were observed between WT
(n=5) and mutant explants (n=4), both in their ability to migrate at the
gel surface aswell as in their potential to invade thegelmatrix. Underour
experimental conditions,WTcells typically extend at the surface beyond
500 μm, andmigrating cells tend to form tube like structures that detach
from themain explant in themost external surface (Fig. 4A left panel). In
contrast, BAF180 mutant explants do not extend beyond 250 μm and
detached cells were not observed (Fig. 4A, right panel).
Differences among genotypes were also observed upon quantiﬁca-
tion of the morphologically distinguishable mesenchymal cells at
different depths of the collagen gel. At the surface level mesenchymal
Fig. 3. Defects in the maturation of the epicardium in BAF180 null embryonic hearts. (A) At E11.5, the subepicardial space in WT is apparent and ﬁlled with cells migrated from the
epicardium. In contrast, the mutant hearts generally form very limited subepicardial space, and there are far fewer cells inside the space, indicating a delayed or defective EMT of the
epicardial cells in mutant hearts. At E12.5 (B) and E14.5 (C), the subepicardial space in mutant hearts is more pronounced than that in control hearts.
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unit (41±5 inWT, compared to 28±7 inKO). At the level of 100 μminside
the gel 26±3 cells were observed per area unit in the WT explants
compared to 5±3 in the KO explants. At the 200 μm level, 3±2 cells were
counted in theWTcultureswhile noKOcellswere foundat this level (Fig.Fig. 4. Evaluation of epithelial-to-mesenchymal transformation inWTandBAF180 KOmice
with the collagen gel assay. (A) Micrographs from representative ﬁelds of WT and KO
explanted epicardia, showing horizontal migration of cultured cells. Observe the reduced
capacity of KO explanted cells to detach from the monolayer. While WT explants typically
reached 500 μm outside the continuous epithelial layer, KO cells did not extend beyond
250 μm(bar=50 μm). (B) Quantiﬁcation of invasion of collagen gel by the explanted cells, as
a directmeasurementof EMT. Averageswere calculatedand comparedusing Student's t test
for two variable comparisons at a level of signiﬁcance of p≤0.05.4B). Therefore, the in vivo and in vitro data demonstrates that BAF180 is
critical for the normal progression of epicardial cells.
BAF180 is essential for the normal development of the ﬁne and
continuous coronary plexus that covers the whole heart
To directly address if BAF180 ablation causes defects in the coronary
vasculature, we applied antibody staining of PECAM, a marker for
endothelial cells, to E12.5–E14.5 BAF180null hearts. Indeed,we observed
abnormal surface nodules in the freshly dissected E14.5 mutant hearts
that are rarely seen inWT hearts (Fig. 5, compare A to B). Whole-mount
PECAM staining showed that these nodules are abnormal structures
resulting from the failure of PECAM-positive cells within them to branch
out to form coronary vessels, similar to what has been observed in
thymosin β4 mutant embryos (Smart et al., 2006). PECAM staining also
indicated that, compared toWThearts, the E14.5 BAF180 null embryonic
hearts are defective in developing the ﬁne and continuous plexus that
covered the entire ventricle (Fig. 5 C, E, and G). Statistical analysis
indicated that the coronary vessel density at the surface of the BAF180
knockout heart ventricles is only about 25 to 40% to that of thewild-type
controls (Fig. 5I). Further, sectioned PECAM staining revealed that the
coronary vessels have little penetration into the myocardium of mutant
hearts (Fig. 5, compare J to K, and L to M). The aberrant nodules
developed in homozygous embryos are less severe in E13.5 andE12.5 KO
embryos (Fig. S1). Together, these data indicate that BAF180 regulates the
proper development of the ﬁne and continuous coronary plexus.
We also examinedwhether the coronary arteries are connected to the
aorta in the mutant hearts, because the connection with systemic blood
circulation provides nutrition and oxygen to the heart during mid-
gestation, and failure to do so would severely compromise the normal
development of the heart. Fig. S2 indicated that like theWTembryos, the
E14.5 BAF180 KO embryos form a normal connection between the
coronary vessels and the aorta.
BAF180 ablation affects the proper lining of smooth muscle and
endothelial cells to form coronary vessels
The above data suggest that BAF180 is critical for the proper EMT
and vasculogenesis of the coronary vasculature (Figs. 3 to 5). The DNA
Fig. 5. Defective embryonic coronary vasculature in BAF180 KO embryonic hearts. (A, B) Ventral view of freshly dissected E14.5 BAF180 KO and WT embryos. (C–H) Whole-mount
PECAM staining of BAF180-deﬁcient (C, D, and G) andWTcontrol (D, F, and H) E14.5 hearts. Ventral view: (C–F) Dorsal view: (G and H) Note the abnormal nodules (asterisks) and the
failure of forming the ﬁne and continuous capillary vessels in themutant hearts (panels C, E, and G). (I) Quantitative analysis of coronary vessel density at the ventricular surface. (J, K)
Histological sections of whole-mount PECAM-stained hearts counter-stained with nuclear fast red. (L, M) Sectioned ﬂuorescent PECAM staining. Note the little penetration of
coronary vessels into the compact zone of myocardium in the mutant hearts (compare panel J to K, and panel L to M). The nodules are indicated by asterisks and the coronary vessels
formed within myocardium are indicated by arrows. Green: PECAM; blue: DAPI.
262 X. Huang et al. / Developmental Biology 319 (2008) 258–266microarray data obtained previously and qRT-PCR data using RNA
samples from BAF180 mutant hearts demonstrated that the α-SMA
expression is down-regulated (Fig. 6A), pointing to the possibility that
the formation of smoothmuscle cells was decreased in BAF180mutant
hearts. α-SMA is mostly expressed in smooth muscle cells, although it
is also expressed in early cardiomyocytes. α-SMA expression in
cardiomyocytes is more prominent before E12.5, and its expression
at E13.5 and E14.5 cardiomyocytes becomes weaker as observed in
comparable stages of avian and rat embryonic hearts (Ruzicka and
Schwartz, 1988; Woodcock-Mitchell et al., 1988). Therefore, PECAM
and α-SMA double-immunostaining assays should further establish
the role of BAF180 in coronary development after E13.5. Since smooth
muscle cells are also present around the aorta and pulmonary trunk
arteries, we ﬁrst examined if the smooth muscle cells surrounding
these vessels are affected.
As illustrated in Fig. 6B, there is no difference of α-SMA-positive cells
in number and density between the mutant and the WT surrounding
aorta and pulmonary trunk arteries, indicating that the formation of
these big vessels is largely unaffected. This is consistent with the idea
that the smooth muscle of the outﬂow tract does not originate from the
epicardium. In contrast, when applying this assay to examine the coro-
nary vessels, we observed that the mutant hearts contain a signiﬁcant
number of individual α-SMA-positive cells within the subepicardialspace in themutant hearts (Fig. 6C, left panels). The mutant hearts form
larger than normal coronary vessels that remain in the surface and
aberrant nodules within the epicardium region (Fig. 6C, left panels),
while the control hearts (Fig. 6C, right panels) form a ﬁne continuous α-
SMA-positive line at certain areas of the epicardium region, and within
the cardiomyocyte compact zone. The PECAM/α-SMA double staining
assay also revealed that the endothelial and smooth muscle cells inside
the nodules are disorganized (Fig. 6C, lower left panel), and in E14.5
embryonic hearts, the nodules grow bigger with a large number of
endothelial and smooth muscle cells trapped inside (Fig. 6D, left panel).
The lack of ﬁne coronary vessels at the surface, devoid of coronary
vessels inside cardiomyocyte layer, and the formation of the aberrant
nodules demonstrate that BAF180 is required for epicardial maturation.
BAF180 regulates various genes and signaling pathways involved in
coronary development
To understand the molecular mechanism BAF180 regulated coro-
nary development, we next systemically examined the expression of
more than 30 genes (Mu et al., 2005) involved in EMT, vasculogenesis,
and angiogenesis in BAF180 mutant hearts. We focused on the gene
expression proﬁle at E11.5 when epicardial defects were ﬁrst
observed. Our quantitative RT-PCR data indicated that the expression
Fig. 6. BAF180 regulates the appropriate lining of endothelial and smooth muscle cells in the coronary vessels and subsequent angiogenesis. (A) qRT-PCR analyses of the relative
expression of α-SMA and PECAM in BAF180 KO hearts. GAPDH was used as an internal control for quantiﬁcation. (B) PECAM/α-SMA double-immunostaining of E13.5 aorta and
pulmonary trunk. No obvious decrease of α-SMA is observed in these vessels. (C) PECAM/α-SMA double-immunostaining of sectioned E13.5 embryonic hearts. The control hearts
(right panels) generally form a ﬁne continuous α-SMA-positive line at a certain area of the epicardium region, and coronary vessels are frequently found in the cardiomyocyte
compact zone region. In contrast, mutant hearts only form larger than normal vessels and aberrant nodules within the epicardium region (left panels). Note the disorganized
endothelial and smoothmuscle cells inside the nodules, and also the individual α-SMA-positive cells within the subepicardial space in the mutant hearts. (D) PECAM/α-SMA double-
immunostaining of sectioned E14.5 embryonic hearts. Note the large number of endothelial and smooth muscle cells trapped in the nodule (left panel). Green, PECAM; red, α-SMA;
blue, DAPI.
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the heart is down-regulated, whereas the expression of Ang-1, Flt1,
Flk1, VEGFC, VEGFR3, Tie1, and Tie2 remains relatively unchanged (Fig.
7A). Genes involved in TGF, FGF, PDGF pathways are selectively down-
regulated, including TGFβ2, TGFR2, FGF9, PDGFB, whereas genes such
as Wnt9b and β-catenin–also involved in epicardial development
(Merki et al., 2005; Zamora et al., 2007) – are largely unaffected (Fig.
7B). These studies identiﬁed a number of important genes involved in
coronary development that are regulated by BAF180, and provided a
framework for establishing the BAF180-mediated transcriptional
network during coronary development.
Discussion
In this study, we identiﬁed the polybromo protein BAF180 as an
important regulator for embryonic coronary development. Lack of
BAF180 leads to impaired EMT of the epicardial cells and arrested
epicardial remodeling at E11.5 hearts. In vivo analysis and in vitro
collagen gel assays revealed that BAF180 mutant epicardial cells are
severely compromised in migration and EMT. Subsequently, BAF180
ablation also results in failure of the development of the ﬁne and
continuous plexus that covers the entire ventricle at later stages.
Furthermore, we observed aberrant nodules at the surface of the
mutant heartswith accumulation of epithelial and smoothmuscle cells
within these structures. We also observed little penetration of the
coronary vessels into the myocardium, strongly suggesting defective
migration of the already reduced number of mesenchymal cells in theBAF180 mutant hearts. In contrast, the formation of the PE, migration
of the PE cells to cover the heart tube, and the connection of coronary
vessels to aorta are all relatively normal in the BAF180 mutant
embryos. Thus, it appears that the major function of BAF180 during
coronary arteriogenesis is to mediate epicardial development.
The observed coronary defects and thin myocardial wall syndrome
in BAF180 mutant hearts appear not due to a gross developmental
delay in embryogenesis. Instead, the modest developmental delay of
E14.5 KO embryos may be secondary to their heart defects. There is
essentially no difference in somite number between WT and mutant
embryos at E11.5 and E12.5 stages (Table S1) when epicardial defects
are already observed (Figs. 3 and 4). The E14.5 KO embryos show
slightly delayed digit segregation and are smaller. The KO embryos
often show characteristic edema along their backs indicating
circulatory defects. We further revealed that the defects are primarily
within the heart (Wang et al., 2004). Mouse embryonic heart
ordinarily develops into its mature form at E14.5 in order to provide
sufﬁcient blood ﬂow for the rapid growth of the fetus. Thus, it is likely
that the defective heart of BAF180 KO embryos would have difﬁculty
sustaining normal circulation, leading to the observed smaller KO
embryos at E14.5, a modest developmental delay around that stage,
and embryonic lethality after that.
The functions of BAF180 in embryonic coronary development (this
study) and cardiac chamber maturation (Wang et al., 2004) are
distinct from those of several core subunits present in both PBAF and
BAF complexes, such as Brg-1, BAF155, and INI1/SNF5 (Bultman et al.,
2000, 2006; Guidi et al., 2001; Kim et al., 2001; Roberts et al., 2000).
Fig. 7. Identiﬁcation of genes involved in EMT, angiogenesis, and vasculogenesis in E11.5 BAF180 knockout embryos. (A) Relative expression of pro-angiogenic genes in BAF180 WT
and mutant hearts. BAF180 expression was used to validate the cDNA sources. (B) Relative expression of genes involved in TGF, FGF, PDGF, Ephrin, and Wnt pathways. P values of the
expression difference between WT and KO hearts for VEGF, Ang-2, FGF9, and PDGFB are less than 0.01, and for VEGFB, TGFβ2, and TGFR2 are less than 0.02.
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implantation stage, andmaternal Brg-1 is essential for zygotic genome
activation after fertilization (Bultman et al., 2006). Interestingly, a
recent study indicates that endocardial Brg-1 regulates the trabecu-
lation of cardiomyocytes (Stankunas et al., 2008). The function of
PBAF-speciﬁc BAF180 is also distinct from the BAF-speciﬁc subunits
BAF250a and BAF250b. We discovered speciﬁc functions of BAF250a
and BAF250b in ES cell pluripotency and BAF250a in early embry-
ogenesis (Gao et al., 2008; Yan et al., 2008), as well as in the proper
lineage development from the primary and secondary heart ﬁelds
(data not shown). These data also suggest that the role in early
embryogenesis found in various core subunits can be largely attri-
buted to the function of BAF, rather than PBAF.
How BAF180-mediated chromatin remodeling regulates EMT and
vasculogenesis needs further investigation. Our qRT-PCR analysis using
RNA prepared from E11.5 embryonic hearts suggests that the down-
regulation of VEGF, VEGFB, and Ang-2 contributes to the defects
observed in BAF180 mutant hearts (Fig. 7A). In an effort to dissect
whether BAF180 regulates these genes directly or regulates the possible
upstream signaling pathways or transcription factors, we also examined
the expression of various genes in select signaling pathways. The
signaling pathways and transcription factors involved in EMT and
angiogenesis during coronary development include RA and erythro-
poietin (epo) (Chen et al., 2002; Merki et al., 2005; Stuckmann et al.,
2003; Wu et al., 1999), Fibroblast growth factors (FGFs) (Lavine et al.,
2006, 2005; Morabito et al., 2001; Pennisi and Mikawa, 2005), and
transforming growth factor-β isoforms (TGFβs) (Morabito et al., 2001;
Olivey et al., 2006; Tavares et al., 2006). Other transcription factors
includeGATA4, friendofGATA2 (FOG2), Ets-1/Ets-2,Wilms tumor1 (WT-1), serum response factor, histone acetyltransferase P300, and TBX5.
BMPs, Ephrins and their receptors, platelet-derived growth factors, and
Notch signaling could also be involved in coronary arteriogenesis (Mu et
al., 2005). Our qRT-PCR analysis indicated that TGFβ2, TGFR2, FGF9 and
PDGFB involved in TGF, FGF, PDGF pathways are selectively down-
regulated, while Wnt9b and β-catenin are largely unaffected (Fig. 7B).
Future studies by chromatin immunoprecipitation assays will likely
reveal whether BAF180 directly regulates the expression of these genes.
Whether BAF180 mediates or works in synergy with RA signaling
to regulate coronary vessel formation remains elusive. Based on
previous in vitro and in vivo analyses, it seems likely that BAF180/PBAF
plays a role in RA signaling during heart development, presumably by
serving as a cofactor for RXRα, PPARγ, and other RA-related nuclear
receptors (Lemon et al., 2001; Wang et al., 2004). Therefore, we
examined the expression of RARα, RARβ, RARγ, RXRα, RXRβ, RXRγ,
and PPARγ. The effect of BAF180 ablation on the expression of these
genes was rather modest (data not shown). Instead of downstream
targets, these receptors are likely potential partners for BAF180. Even
though the six RA receptors involved in RA signaling are not affected
in BAF180 mutant hearts (data not shown), our previous studies
indicate that BAF180 regulates certain genes involved in RA signaling
(Wang et al., 2004). Another study reveals that FGF signaling to the
cardiomyoblast controls a wave of Hedgehog signaling, which in turn
activates the expression of VEGF-A, -B, -C, and Ang-2 that are essential
for coronary vascular development (Lavine et al., 2006). And
interestingly, part of this FGF signaling mediated by FGF9 is regulated
by RA signaling (Lavine et al., 2005). The down-regulation of FGF9,
VEGF-A, -B, and Ang-2 in BAF180 knockout embryonic hearts suggests
that BAF180 is indeed involved in RA and FGF signaling. Our further
265X. Huang et al. / Developmental Biology 319 (2008) 258–266analysis also indicates that BAF180 regulates the expression of a few
early genes in RA pathway in a dynamic- and stage-speciﬁc pattern
(data not shown). Future in vivo and in vitro studies will help better
understand the transcriptional network and hierarchy mediated by
chromatin remodeling complex PBAF during coronary development.
Even though most molecules and signaling pathways involved in
coronary development appear to have a general role in vasculogenesis,
the function of BAF180 is more critical in the coronary vasculature.
We only observed subtle defects in the vasculature of yolk sac and
embryonic bodies (Fig. S2 and data not shown), suggesting coronary
development either requires speciﬁc BAF180 mediated chromatin
remodeling or is more sensitive to the alteration of chromatin re-
modeling mediated gene network.
An intriguing question that needs further genetic investigation is
whether BAF180 functions only in epicardium to regulate the proper
expression of factors identiﬁed in this study. It has beenwell established
that signals derived from the PE, epicardium, and myocardium, and
maybe even from the endocardium and neural crest are important for
the coronary development. For example, RA and erythropoietin (epo)
signals are generated in epicardial cells to activate gene expression that
promotes coronary growth and myocardium proliferation (Chen et al.,
2002; Merki et al., 2005; Stuckmann et al., 2003; Wu et al., 1999).
Fibroblast growth factors (FGFs) from both epicardium andmyocardium
are required for EMT and vasculogenesis (Lavine et al., 2006, 2005;
Morabito et al., 2001; Pennisi and Mikawa, 2005). Wnt/β-catenin
signaling from epicardium is essential for the coronary artery formation
(Zamora et al., 2007). In addition, progenitors from the secondary heart
ﬁeld and neural crest can physically contribute to the formation of
outﬂow tract and major coronary arteries (Jiang et al., 2000; Moretti et
al., 2006). The normal development of the outﬂow tract and major
coronary arteries in BAF180 knockout embryonic hearts suggest that the
observed defects in coronary development are not due to BAF180's
function in the tissues derived from secondary heart ﬁeld or neural crest.
Consistent with this, our conditional knockout studies indicated that
ablation of BAF180 in the cardiac heart tubemediated byMlc-2v-Cre and
Nkx2.5-Cre does not have much effect on the coronary vessel formation
(data not shown), suggesting that epicardium could be the primary
target tissue forBAF180, and the thinmyocardialwall syndromereported
previously could be secondary to coronary defects.
It will be critical to investigate whether a timely over-expression of
BAF180 can promote the multipotency of epicardial progenitor cells. A
few recent studies point to the therapeutic potential of epicardial
progenitors from the PE and epicardium. Epicardial progenitor cells can
maintain their multipotency even into adulthood. In zebraﬁsh, cardiac
regeneration after resection of the ventricular apex requires the
activation of the entire epicardial cell layer, and a subset of these cells
undergoes EMT to generate new vasculature for regenerating muscle
(Lepilina et al., 2006). In both mouse and human, adult epicardial cells
can undergo EMT to produce smooth muscle like cells under deﬁned
conditions (Smart et al., 2006; van Tuyn et al., 2007). The PE-derived
progenitor cells might even be able to differentiate into cardiac muscle
cells (Kruithof et al., 2006). These studies indicate the promising
therapeutic potential of the epicardial cells. Therefore, it is of paramount
importance to identify the factors or epigenetic modiﬁcations that can
regulate the multipotency of these progenitor cells. The identiﬁcation
and characterization of BAF180 in coronary development and the
elucidation of the orchestrated function of BAF180 and other transcrip-
tion factors for coronary vasculogenesis and neovascularization will
ultimately lead to a better understanding of the etiology of coronary
related heart diseases, and may help us develop new therapeutic
interventions to prevent and treat these diseases.
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